Sun Nuclear's SunCheck nets more than 1,000 global users
January 11, 2021 -- Radiation oncology quality-assurance technology developer Sun Nuclear has announced that its SunCheck quality management platform has netted more than 1,000 users in almost 60 countries.
January 11, 2021 -- Radiation oncology quality-assurance technology developer Sun Nuclear has announced that its SunCheck quality management platform has netted more than 1,000 users in almost 60 countries.
RefleXion partners with HealthMyne on cancer radiomics
January 8, 2021 -- Radiation therapy developer RefleXion Medical has signed a deal with HealthMyne to combine technologies to apply oncology radiomics to radiation therapy treatments.
January 8, 2021 -- Radiation therapy developer RefleXion Medical has signed a deal with HealthMyne to combine technologies to apply oncology radiomics to radiation therapy treatments.
ImaginAb, Pfizer ink deal on PET agent
January 8, 2021 -- Imaging agent developer ImaginAb signed a multiyear, nonexclusive license with Pfizer to supply the zirconium-89 CD8 Immuno-PET agent, which can be used to image CD8 T cells in cancer patients.
January 8, 2021 -- Imaging agent developer ImaginAb signed a multiyear, nonexclusive license with Pfizer to supply the zirconium-89 CD8 Immuno-PET agent, which can be used to image CD8 T cells in cancer patients.
Avacta inks license agreement with Point Biopharma
January 7, 2021 -- Avacta Group has signed a license agreement with Point Biopharma to provide that company with access to its pre/Cision technology for developing tumor-activated radiopharmaceuticals.
January 7, 2021 -- Avacta Group has signed a license agreement with Point Biopharma to provide that company with access to its pre/Cision technology for developing tumor-activated radiopharmaceuticals.
ViewRay prepares for $50M stock offering
January 5, 2021 -- Image-guided radiation therapy vendor ViewRay expects to raise approximately $50 million in gross proceeds from a public offering of its common stock this week.
January 5, 2021 -- Image-guided radiation therapy vendor ViewRay expects to raise approximately $50 million in gross proceeds from a public offering of its common stock this week.
Accuray nets FDA nod for ClearRT imaging technology
January 5, 2021 -- Radiation oncology firm Accuray has garnered U.S. Food and Drug Administration (FDA) 510(k) clearance for its ClearRT helical kilovoltage CT imaging technology.
January 5, 2021 -- Radiation oncology firm Accuray has garnered U.S. Food and Drug Administration (FDA) 510(k) clearance for its ClearRT helical kilovoltage CT imaging technology.
Report: COVID-19 causing radioisotope delays
January 4, 2021 -- A drop in the volume of passenger airline travel is causing delays in the shipment of medical radioisotopes from sources in Canada, according to a January 3 report by Reuters.
January 4, 2021 -- A drop in the volume of passenger airline travel is causing delays in the shipment of medical radioisotopes from sources in Canada, according to a January 3 report by Reuters.
ViewRay posts mixed financial results for Q4, year
January 4, 2021 -- Image-guided radiation therapy vendor ViewRay reported a sharp decline in revenues for its fiscal year 2020 compared with the year before, but it was able to reverse the trend in the fourth quarter.
January 4, 2021 -- Image-guided radiation therapy vendor ViewRay reported a sharp decline in revenues for its fiscal year 2020 compared with the year before, but it was able to reverse the trend in the fourth quarter.
ASTRO lauds delay of radiation therapy payment reform
December 22, 2020 -- The American Society for Radiation Oncology (ASTRO) is lauding a provision included in the massive U.S. government spending bill passed December 21 that would push to January 2022 implementation of payment reform for radiation therapy procedures.
Discuss
December 22, 2020 -- The American Society for Radiation Oncology (ASTRO) is lauding a provision included in the massive U.S. government spending bill passed December 21 that would push to January 2022 implementation of payment reform for radiation therapy procedures.
Discuss Shine breaks ground for new headquarters
December 17, 2020 -- Shine Medical Technologies has broken ground in Janesville, WI, on a 54,000-sq-ft facility that will serve as its headquarters and a production facility for its new therapeutics division, established in 2019.
December 17, 2020 -- Shine Medical Technologies has broken ground in Janesville, WI, on a 54,000-sq-ft facility that will serve as its headquarters and a production facility for its new therapeutics division, established in 2019.
Special Feature
IMV: Imaging boosts precision in radiation therapy
Radiation therapy is a relatively stable market, with procedure volume growing at an average annual rate of 2%. But major technological changes in radiation oncology are brewing under the surface, according to a new report by IMV Medical Information Division. Read more
VENDOR CONNECT